Evaluation Of PF-00572778 And Alprazolam On Naloxone Challenge In Healthy Subjects

PHASE1TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2007

Study Completion Date

February 29, 2008

Conditions

Healthy

Interventions

DRUG

alprazolam

tablet, 0.5 mg, single dose, only on Day 7 of the study

OTHER

Placebo

solution, matching placebo to 500 mg PF-00572778, single dose, Days 1 and 7 of the study

DRUG

PF-00572778

solution, 500 mg, single dose, only on Day 7 of the study

Trial Locations (1)

Pfizer Investigational Site, New Haven